Featured Research

from universities, journals, and other organizations

Surgeons Say Minimally Invasive Lung Surgery Should Be Standard Care

Date:
July 2, 2007
Source:
University of Cincinnati
Summary:
Major US academic medical centers can successfully -- and safely -- integrate minimally invasive lung surgery into their training programs with a standardized, step-by-step plan, according to University of Cincinnati thoracic surgeons. It's estimated that only about 10 percent of all lung cancer operations nationwide are done with minimally invasive techniques, but more than half the patients who need the surgery would qualify for the less invasive procedure, which results in faster recovery time and less pain for patients.

UC thoracic surgeons Sandra Starnes, MD, (middle) and Michael Reed, MD, talk to a group of visiting surgeons about minimally invasive lung surgery during a training lab.
Credit: Image courtesy of University of Cincinnati

Major U.S. academic medical centers can successfully--and safely--integrate minimally invasive lung surgery into their training programs with a standardized, step-by-step plan, according to University of Cincinnati (UC) thoracic surgeons.

It's estimated that only about 10 percent of all lung cancer operations nationwide are done with minimally invasive techniques, but more than half the patients who need the surgery would qualify for the less invasive procedure, which results in faster recovery time and less pain for patients.

The minimally invasive lung surgery, known as a thoracoscopic lobectomy, is done through several small incisions, versus a major chest incision, and requires no rib spreading. UC is one of only a handful of academic medical centers actively training surgeons to perform the procedure.

"Thoracoscopic lobectomy should be considered the standard of care for patients with early-stage lung cancers," says Michael Reed, MD, assistant professor of surgery at UC and minimally invasive thoracic surgeon at University Hospital. "But few surgeons offer the procedure because it's difficult and requires a lot of additional training."

"We've shown that with a predetermined, step-by-step plan--guided by highly experienced minimally invasive thoracic surgeons--thoracoscopic lobectomy can be integrated safely into thoracic surgical training programs."

Using this strategy, the UC surgeons have increased the number of minimally invasive lobectomies they perform by about 57 percent over four years. Reed estimates 75 percent of all lobectomies at University Hospital are now done using the minimally invasive approach.

Prior to implementation of the training program, only about 18 percent of lobectomies were performed minimally invasively.

Reed will present the findings on Friday, June 29, at the Western Thoracic Surgical Association's annual meeting in Santa Ana Pueblo, New Mexico.

Reed and UC colleague Sandra Starnes, MD, conducted a four-year review of thoracic surgical cases at University Hospital and the Cincinnati Department of Veterans Affairs Medical Center to compare minimally invasive lobectomies performed by their team before and after implementation of a formal training program.

The Cincinnati team has trained two cardiothoracic surgery fellows and more than a dozen community thoracic surgeons to perform minimally invasive lung surgery.

"The key to implementing this program into our practice was having a dedicated team of extensively trained thoracic surgeons with expertise in both open and minimally invasive, video-guided techniques," adds Starnes. "This isn't a procedure you can perform confidently after just a few cases--mentorship and experience are key."

Collaborators in this study include Mark Lucia, Sandra Starnes, MD, Walter Merrill, MD, and John Howington, MD, who completed this work at UC and is now in private practice at Evanston Hospital in Illinois.


Story Source:

The above story is based on materials provided by University of Cincinnati. Note: Materials may be edited for content and length.


Cite This Page:

University of Cincinnati. "Surgeons Say Minimally Invasive Lung Surgery Should Be Standard Care." ScienceDaily. ScienceDaily, 2 July 2007. <www.sciencedaily.com/releases/2007/06/070629193359.htm>.
University of Cincinnati. (2007, July 2). Surgeons Say Minimally Invasive Lung Surgery Should Be Standard Care. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2007/06/070629193359.htm
University of Cincinnati. "Surgeons Say Minimally Invasive Lung Surgery Should Be Standard Care." ScienceDaily. www.sciencedaily.com/releases/2007/06/070629193359.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins